AcelRx Pharmaceuticals to Present at the Piper Jaffray 24th Annual Healthcare
REDWOOD CITY, Calif., Nov. 20, 2012
REDWOOD CITY, Calif., Nov. 20, 2012 /PRNewswire/ -- AcelRx Pharmaceuticals,
Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the
development and commercialization of innovative therapies for the treatment of
acute and breakthrough pain, today announced that Richard King, President and
CEO, will present a corporate overview at the Piper Jaffray 24^th Annual
Healthcare Conference at The New York Palace in New York, NY. The
presentation is scheduled for Tuesday, November 27, 2012 at 11:00 a.m. ET/8:00
SOURCE AcelRx Pharmaceuticals, Inc.
Contact: Jim Welch, Chief Financial Officer, +1-650-216-3511,
Press spacebar to pause and continue. Press esc to stop.